Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic: A Randomized, Double Blind, Placebo Parallel Controlled Clinical Study

NCT05663307 is registered in ClinicalTrials.gov with Shanghai Yueyang Integrated Medicine Hospital as lead sponsor.

NCT NCT05663307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05663307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic: A Randomized, Double Blind, Placebo Parallel Controlled Clinical Study
Lead sponsor
Shanghai Yueyang Integrated Medicine Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 1, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute